标题
Innate immunity: the first line of defense against SARS-CoV-2
作者
关键词
-
出版物
NATURE IMMUNOLOGY
Volume 23, Issue 2, Pages 165-176
出版商
Springer Science and Business Media LLC
发表日期
2022-02-02
DOI
10.1038/s41590-021-01091-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis
- (2021) Armin Bayati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NINJ1 mediates plasma membrane rupture during lytic cell death
- (2021) Nobuhiko Kayagaki et al. NATURE
- MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
- (2021) Xin Yin et al. Cell Reports
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- (2021) Serge Bureau et al. Lancet Respiratory Medicine
- COVID-19 and the human innate immune system
- (2021) Joachim L. Schultze et al. CELL
- Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
- (2021) Daisy A. Hoagland et al. IMMUNITY
- Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
- (2021) Emanuele Pontali et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells
- (2021) Antoine Rebendenne et al. JOURNAL OF VIROLOGY
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
- (2021) Adam Booth et al. PLoS One
- SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
- (2021) Jing Wu et al. Cell Reports
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
- (2021) Jordan J Feld et al. Lancet Respiratory Medicine
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19
- (2021) Sascha Jung et al. Science Advances
- SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway
- (2021) Grant R. Campbell et al. iScience
- SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
- (2021) André C. Ferreira et al. Cell Death Discovery
- SARS-CoV-2 spike protein interacts with and activates TLR41
- (2021) Yingchi Zhao et al. CELL RESEARCH
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
- (2021) Rebecca Forman et al. HEALTH POLICY
- Linkage of Lambda Interferons in Protection Against Severe COVID-19
- (2021) Mehdi Shahbazi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Downregulation of type III interferons in patients with severe COVID‐19
- (2021) Yosuke Fukuda et al. JOURNAL OF MEDICAL VIROLOGY
- SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways
- (2021) Lulu Han et al. JOURNAL OF MEDICAL VIROLOGY
- Functional landscape of SARS-CoV-2 cellular restriction
- (2021) Laura Martin-Sancho et al. MOLECULAR CELL
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
- (2021) Min Zheng et al. NATURE IMMUNOLOGY
- RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
- (2021) Taisho Yamada et al. NATURE IMMUNOLOGY
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
- (2021) Prasanna Jagannathan et al. Nature Communications
- SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1
- (2021) Liyan Sui et al. Frontiers in Immunology
- COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
- (2021) Jenneke Leentjens et al. Lancet Haematology
- ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
- (2021) GuanQun Liu et al. Nature Microbiology
- A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection
- (2021) Fiachra Humphries et al. Science Immunology
- Pharmacological activation of STING blocks SARS-CoV-2 infection
- (2021) Minghua Li et al. Science Immunology
- Pulmonary Thrombosis and Thromboembolism in COVID-19
- (2021) Hooman D. Poor CHEST
- SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
- (2021) Lucy G Thorne et al. EMBO JOURNAL
- Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
- (2021) Sebastian J Theobald et al. EMBO Molecular Medicine
- Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
- (2021) Roberto Caricchio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
- (2021) Jonathan Lopez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Innate lymphoid cells (ILC) in SARS-CoV-2 infection
- (2021) Amrita Kumar et al. MOLECULAR ASPECTS OF MEDICINE
- Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
- (2021) Florian A. Lempp et al. NATURE
- AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
- (2021) SangJoon Lee et al. NATURE
- Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity
- (2021) Shuai Wang et al. NATURE CELL BIOLOGY
- Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
- (2021) Jack Chun-Chieh Hsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block
- (2021) James M. Burke et al. RNA
- The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
- (2021) Rajendra Karki et al. TRENDS IN IMMUNOLOGY
- The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients
- (2021) Lindsay A. Ritter et al. JOURNAL OF INTENSIVE CARE MEDICINE
- SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10
- (2021) André M. C. Gomes et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
- (2021) Ivan O. Rosas et al. INTENSIVE CARE MEDICINE
- A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
- (2021) Tianyang Mao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fostering experimental and computational synergy to modulate hyperinflammation
- (2021) Ilya Potapov et al. TRENDS IN IMMUNOLOGY
- ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
- (2021) Rajendra Karki et al. Cell Reports
- Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
- (2021) Aránzazu Sancho-López et al. Infectious Diseases and Therapy
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Sensing in the Innate Immune Response
- (2020) Benoit Briard et al. PHYSIOLOGY
- Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?
- (2020) Mayda Gursel et al. ALLERGY
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- The Architecture of SARS-CoV-2 Transcriptome
- (2020) Dongwan Kim et al. CELL
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
- (2020) Min Zheng et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
- (2020) Zahra Belhadjer et al. CIRCULATION
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development
- (2020) Sannula Kesavardhana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
- (2020) Shelbi Christgen et al. Frontiers in Cellular and Infection Microbiology
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis
- (2020) Keshav K. Singh et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Presence of antiphospholipid antibodies in COVID-19: case series study
- (2020) Luis M Amezcua-Guerra et al. ANNALS OF THE RHEUMATIC DISEASES
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
- (2020) Nan Wang et al. Cell Host & Microbe
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- (2020) Caspar I. van der Made et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of SARS-CoV-2 by type I and type III interferons
- (2020) Ulrike Felgenhauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection
- (2020) Min Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
- (2020) Megan L. Stanifer et al. Cell Reports
- LY6E impairs coronavirus fusion and confers immune control of viral disease
- (2020) Stephanie Pfaender et al. Nature Microbiology
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
- (2020) Rajendra Karki et al. JCI Insight
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
- (2020) Evangelos J. Giamarellos-Bourboulis et al. CELL
- Intracellular innate immune receptors: Life inside the cell
- (2020) Thirumala‐Devi Kanneganti IMMUNOLOGICAL REVIEWS
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
- (2020) SangJoon Lee et al. TRENDS IN IMMUNOLOGY
- The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- (2020) Jin-Yan Li et al. VIRUS RESEARCH
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
- (2020) Yoriyuki Konno et al. Cell Reports
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
- (2020) Maria Orietta Borghi et al. Frontiers in Immunology
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- A Crisp(r) New Perspective on SARS-CoV-2 Biology
- (2020) Adam L. Bailey et al. CELL
- Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study
- (2020) Daniele Generali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Increased secondary infection in COVID-19 patients treated with steroids in New York City
- (2020) Reiichiro Obata et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)
- (2020) Balaji Banoth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
- (2020) Magali Noval Rivas et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production
- (2020) Keli Chen et al. Viruses-Basel
- SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
- (2020) Ganna Petruk et al. Journal of Molecular Cell Biology
- Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
- (2019) Kam-Leung Siu et al. FASEB JOURNAL
- Inflammasomes and the fine line between defense and disease
- (2019) Shelbi Christgen et al. CURRENT OPINION IN IMMUNOLOGY
- Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
- (2019) R.K. Subbarao Malireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
- (2018) R.K. Subbarao Malireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- STING-dependent translation inhibition restricts RNA virus replication
- (2018) Kate M. Franz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of C-Reactive Protein at Sites of Inflammation and Infection
- (2018) Nicola R. Sproston et al. Frontiers in Immunology
- Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation
- (2018) Susan J. Burke et al. Molecular Metabolism
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β–mediated osteomyelitis
- (2016) Prajwal Gurung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Guarding the frontiers: the biology of type III interferons
- (2015) Andreas Wack et al. NATURE IMMUNOLOGY
- Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses
- (2015) Zhe Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- (2015) Jose L. Nieto-Torres et al. VIROLOGY
- FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes
- (2014) P. Gurung et al. JOURNAL OF IMMUNOLOGY
- Dietary modulation of the microbiome affects autoinflammatory disease
- (2014) John R. Lukens et al. NATURE
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
- (2013) John W. Schoggins et al. NATURE
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Intranasal Treatment with Poly(I{middle dot}C) Protects Aged Mice from Lethal Respiratory Virus Infections
- (2012) J. Zhao et al. JOURNAL OF VIROLOGY
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Immune Signaling by RIG-I-like Receptors
- (2011) Yueh-Ming Loo et al. IMMUNITY
- Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
- (2011) S. M. Horner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cutting Edge: Proteolytic Inactivation of Poly(ADP-Ribose) Polymerase 1 by the Nlrp3 and Nlrc4 Inflammasomes
- (2010) R. K. S. Malireddi et al. JOURNAL OF IMMUNOLOGY
- TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1β and caspase-1 in monocytes and dendritic cells
- (2009) Julia Hurst et al. IMMUNOBIOLOGY
- Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8
- (2009) Yvonne Döring et al. IMMUNOBIOLOGY
- Targeted Peptidecentric Proteomics Reveals Caspase-7 as a Substrate of the Caspase-1 Inflammasomes
- (2008) Mohamed Lamkanfi et al. MOLECULAR & CELLULAR PROTEOMICS
- SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
- (2008) Kèvin Knoops et al. PLOS BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now